#ASH19

Mike Thompson, MD, PhD, FASCO

@mtmdphd.bsky.social

6 months ago

Real-World Myeloma Pts Remain Under-Represented in #ClinicalTrials Based on Standard Labs & Baseline Characteristics: Analysis of over 3,000 Pts from @TakedaOncology Insight - @dra_v_hungria et al. @AjaiChari - Abs 1887 #ASH19 ashpublications.org/blood/articl... #mmsm

Miguel Perales MD

@drmiguelperales.bsky.social

1 year ago

#ASH19 #ASHThrowback a composite of many former @mskcancercenter.bsky.social talented fellows & visiting investigators too many to name but now all successful faculty at #MSK and other centers in US and Europe - A lot of fun to see them grow & succeed #mentorship #hematology #bmtsm #CARTcells #ASH24

American Society of Hematology

@ash.hematology.org

1 year ago

Love this #ASHThrowback to #ASH19, which shows that traveling can be part of the fun! We can't wait to see you at #ASH24!

Emma M. Groarke

@emmamgroarke.bsky.social

1 year ago

#ASHThrowback - my first time giving a talk at an international conference! #ASH19 discussed our work on pediatric #SAA patients treated with eltrombopag + IST @ash-hematology.bsky.social

Andrea P. Fischer

@andreapfischer.bsky.social

1 year ago

My #ASHThrowback is from #ASH19 when @statnews.bsky.social featured the debut of the Napods! Don't worry, they will be back for #ASH24 in San Diego!